Waters (NYSE:WAT) Now Covered by Analysts at Stifel Nicolaus

Share on StockTwits

Equities researchers at Stifel Nicolaus assumed coverage on shares of Waters (NYSE:WAT) in a research note issued on Thursday, The Fly reports. The firm set a “hold” rating on the medical instruments supplier’s stock.

Several other equities analysts have also recently issued reports on the stock. Needham & Company LLC reissued a “hold” rating on shares of Waters in a research note on Tuesday, October 29th. Barclays cut shares of Waters from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $210.00 to $195.00 in a research note on Wednesday, October 9th. TheStreet cut shares of Waters from a “b” rating to a “c+” rating in a research note on Tuesday, October 29th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Robert W. Baird boosted their price objective on shares of Waters from $208.00 to $217.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Six research analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $209.60.

Shares of WAT opened at $217.32 on Thursday. The company has a debt-to-equity ratio of 11.40, a quick ratio of 1.63 and a current ratio of 2.25. The stock has a market capitalization of $13.70 billion, a P/E ratio of 26.21, a P/E/G ratio of 2.53 and a beta of 1.04. The company’s fifty day moving average is $216.51 and its two-hundred day moving average is $213.81. Waters has a 1 year low of $173.41 and a 1 year high of $255.21.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, October 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.13. The company had revenue of $577.28 million for the quarter, compared to analysts’ expectations of $588.35 million. Waters had a net margin of 23.98% and a return on equity of 77.73%. Waters’s revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.92 EPS. Sell-side analysts predict that Waters will post 8.84 EPS for the current year.

In other Waters news, SVP Elizabeth B. Rae sold 29,326 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $213.12, for a total transaction of $6,249,957.12. Following the sale, the senior vice president now directly owns 23,932 shares in the company, valued at approximately $5,100,387.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Laurie H. M.D. Glimcher sold 2,200 shares of the business’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $214.64, for a total transaction of $472,208.00. Following the sale, the director now owns 3,600 shares in the company, valued at $772,704. The disclosure for this sale can be found here. Insiders have sold a total of 33,901 shares of company stock worth $7,228,491 over the last 90 days. Insiders own 1.14% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of WAT. Compagnie Lombard Odier SCmA purchased a new stake in shares of Waters in the 2nd quarter worth about $37,000. CSat Investment Advisory L.P. boosted its position in shares of Waters by 212.5% in the 2nd quarter. CSat Investment Advisory L.P. now owns 225 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 153 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of Waters in the 3rd quarter worth about $51,000. Private Capital Group LLC boosted its position in shares of Waters by 92.0% in the 2nd quarter. Private Capital Group LLC now owns 288 shares of the medical instruments supplier’s stock worth $56,000 after buying an additional 138 shares in the last quarter. Finally, Amica Retiree Medical Trust purchased a new stake in shares of Waters in the 2nd quarter worth about $69,000. Institutional investors own 99.56% of the company’s stock.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More: Which market index is the best?

The Fly

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: BCB Bancorp, Inc.  Given Consensus Recommendation of “Buy” by Analysts
Zacks: BCB Bancorp, Inc. Given Consensus Recommendation of “Buy” by Analysts
Wells Fargo & Co Increases Greif  Price Target to $46.00
Wells Fargo & Co Increases Greif Price Target to $46.00
Hartford Financial Services Group  Downgraded by Royal Bank of Canada
Hartford Financial Services Group Downgraded by Royal Bank of Canada
Jeld-Wen  Earns Neutral Rating from Analysts at Goldman Sachs Group
Jeld-Wen Earns Neutral Rating from Analysts at Goldman Sachs Group
Installed Building Products  Now Covered by Goldman Sachs Group
Installed Building Products Now Covered by Goldman Sachs Group
SINGAPORE AIRL/ADR  Stock Price Down 2.5%
SINGAPORE AIRL/ADR Stock Price Down 2.5%


© 2006-2019 Ticker Report